The Hemodynamic Effects of Calcium Channel Blocking Agents: A Brief Review

Abstract

Get full access to this article

View all access options for this article.

References

Fleckenstein A. : Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu Rev Pharmacol Toxicol 17:149-166, 1977.

Fleckenstein A. : Specific inhibitors and promotors of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: Calcium and the Heart, ed. by Fleckenstein H , Opie LH , London, Academic Press , 1970.

Haeusler G. : Differential effects of verapamil on excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic terminals. J Pharmacol Exp Ther 180:672-679, 1972.

Krikler D. : Verapamil in cardiology. Eur J Cardiol 2:3-10, 1974.

Singh BN , Ellrodt G. , Peter CT : Verapamil: A review of its pharmacologic properties and therapeutic use. Drugs 15:169-197, 1978.

Henry PD : Calcium ion (Ca2+) antagonist: mechanism of action and clinical applications . Prac Cardiol 5:1450-1456, 1979 .

Ellrodt G. , Chew Cyc , Singh BN : Therapeutic implications of slow channel blockade in cardiocirculatory disorders . Circulation 62:669-679, 1980.

Antman EM , Stone PH , Muller JE , Braunwald E. : Calcium channel blocking agents in the treatment of cardiovascular disorders: I. Basic and clinical electrophysiologic effects. Ann Intern Med 93:875-885, 1980.

Stone PH , Antman EM , Muller JE , Braunwald E. : Calcium channel blocking agents in the treatment of cardiovascular disorders: II. Hemodynamic and clinical applications. Ann Intern Med 93:886-904, 1980.

10.

Hille B. : Ionic channels in excitable membranes: Current problems and biophysical approaches . Biophys J 22:283-294, 1978.

11.

Almers W. : Gating currents and charge movements in excitable membranes. Rev Physiol Biochem Pharmacol 82:96-190, 1978.

12.

Katz AM : Contractile proteins of the heart. Physiol Rev 50:63-158, 1970.

13.

Langer GA : Heart: excitation-contraction coupling. Ann Rev Physiol 35:55-86, 1973.

14.

Fabiato A. , Fabiato F. : Calcium and cardiac excitation-contraction coupling. Ann Rev Physiol 41:473-484, 1979.

15.

Adelstein RS : Hathaway DR: Role of calcium and cyclic adenosine 3':5' monophosphate in regulating smooth muscle contraction: Mechanisms of excitation-contraction coupling in smooth muscle. Am J Cardiol 44:783-787, 1979.

16.

Henry PD : Chronotropic and inotropic effects of coronary vasodilators. In: Adalat: New Experimental and Clinical Results. Amsterdam , Excerpta Medica, 1979, pp. 3-4.

17.

Nayler WG , Szeto J. : Effect of verapamil on contractility oxygen utilization, and calcium exchange ability in mammalion heart muscle. Cardiovasc Res 6:120-128, 1972.

18.

Nakajima H. , Hoshiyana M. , Yamashita K. , Kiyomoto A. : Effect of diltiazem on electrical and mechanical activity of isolated cardiac ventricular muscle of guinea pig. Jpn J Pharmacol 25:383-392, 1975.

19.

Mangiardi LM , Hariman RJ , McAllister RG Jr, et al: Electrophysiologic and hemodynamic effects of verapamil correlation with plasma drug concentrations. Circulation 57:366-372, 1978.

20.

Refsum H. , Landmark K. : The effects of a calcium antagonistic drug, nifedipine, on the mechanical and electrical activity of the isolated rat atrium. Acta Pharmacol Toxicol 37:369-376, 1975.

21.

Mannhold R. , Steiner R. , Haas W. , Kaufmann R. : Investigations on the structure-activity relationships of verapamil. Naunyn Schmiedebergs Arch Pharmacol 310:69-78, 1979.

22.

Lydtin H. , Lohmoller R. , Schmitz H. , Walter I. : Hemodynamic studies on Adalat in healthy volunteers and in patients. In: Second International Adalat Symposium: New Therapy of Ischemic Heart Disease, ed. by Lochner W , Braasch W , Kroneberg G. Berlin, Excerpta Medica, 1975, pp. 112-123.

23.

Lichtlen H. , Engel J. , Wolf R. , Amende I. : The effect of the calcium antagonistic drug nifedipine on coronary and left ventricular dynamic in patients with coronary heart disease. In: Calcium Antagonismus, ed. by Fleckenstein A , Roskamm H. Heidelberg , Springer -Verlag, 1980, pp. 270-281.

24.

Lynch P. , Dangie H. , Krikler S. , Krikler D. : Objective assessment of anti-anginal treatment:A double-blind comparison of propranolol, nifedipine, and their combination. Br Med J 280:184-187, 1980.

25.

Anastassiades CJ : Nifedipine and beta-blocking drugs. Br Med J 281:1251-1252, 1981.

26.

Opie LH , White DA : Adverse interaction between nifedipine and B-blockade. Br Med J 281:1462, 1981.

27.

Vincenzi M. , Allegri P. , Gabaldo S. , et al: Comparison of hemodynamic effects caused by I.V. administration of verapamil in healthy subjects. Arzneim Forsch 26:1221-1223, 1976.

28.

Atterhog JH , Ekelund LG : Hemodynamic effects of intravenous verapamil at rest and during exercise in subjectively healthy middle-aged men. Eur J Clin Pharmacol 8:317-322, 1975.

29.

Lewis BS , Mitha AS , Gotsman MS : Immediate hemodynamic effects of verapamil in man. Cardiology 60:366-376, 1975.

30.

Ryden L. , Saetre H. : The hemodynamic effect of verapamil. Eur J Clin Pharmacol 3:153-156, 1971.

31.

Ross G. , Jorgensen CR : Cardiovascular action of iproveratril. J Pharmacol Exp Ther 158:504-509, 1967.

32.

Nayler WG , McInnes I. , Swann JB , et al: Some effects of iproveratril (Isoptin) on the cardiovascular system. J Pharmacol Exp Ther 161:247-261, 1968.

33.

Angus JA , Dhumma-Upahorn P. , Cobbun LB , Goodman AH : Cardiovascular action of verapamil in the dog with particular reference to myocardial contractility and atrioventricular conduction. Cardiovasc Res 10:623-632, 1976.

34.

Singh BN , Roche Ahg : Effects of intravenous verapamil on hemodynamics in patients with heart disease . Am Heart J 94:593-599, 1977.

35.

Ferlinz J. , Easthope J. , Aronow WS : Effects of verapamil on myocardial performance in coronary disease. Circulation 59:313-319, 1979.

36.

Rackley CE : Quantitative evaluation of left ventricular function by radiographic techniques . Circulation 54:862-879, 1976.

37.

Chew Cyc , Hecht HS , Collett JT , et al: Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease . Am J Cardiol 47:917-922, 1981.

38.

Benalm ME : Asystole after verapamil. Br Med J 2:169-170, 1972.

39.

Boothby GB , Garrard CS , Pickering D. : Intravenous verapamil in cardiac arrhythmias. Br Med J 2:349, 1972.

40.

Seabra-Gomes R. , Richards A. , Sutton R. : Hemodynamic effects of verapamil and practolol in man. Eur J Cardiol 4:79-85, 1976.

41.

Leon MB , Rosing DR , Bonow RO , et al: Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoria. Am J Cardiol 48:131-139, 1981.

42.

Bowles M. , Subramanian V. , Davies AB , Raftery EB : Comparison of the antianginal action of verapamil and propranolol. Br Med J 282:1754, 1981.

43.

Kieval J. , Kirsten EB , Kessler KM , et al: The effects of intravenous verapamil on hemodynamic status of patients with coronary artery disease receiving propranolol. Circulation 65:653-659, 1982.

44.

Kinoshita M. , Motomura M. , Kusukawa R. , Kawakita S. : Comparison of hemodynamic effects between B-blocking agents and a new antianginal agent, diltiazem hydrochloride. Jpn Circulation J 43:587-598, 1979.

45.

Kusukawa R. , Kinoshita M. , Shimono Y. , et al: Hemodynamic effects of a new antianginal drug, diltiazem hydrochloride. Arznein Forsch 27:878-887, 1977.